IOSP
INNOSPEC INC.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$97.99
+1.22%Year over year
Reported trailing growth
- Revenue
- +2.9%
- EBITDA
- -12.7%
- EBIT
- -8.4%
- EPS
- +537.7%
- Free cash flow
- -25.3%
- Operating cash flow
- -8.3%
Forward estimates
Based on analyst estimates
- Revenue
- +10.1%
- EBITDA
- +28.1%
- EPS
- +22.8%
Three-year CAGR
- Revenue
- -3.3%
- EBITDA
- -7.0%
- EBIT
- -5.9%
- Net income
- -4.3%
- EPS
- -4.4%
- Free cash flow
- +30.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026